In-stent restenosis | Controls | p | |
---|---|---|---|
Age (years) | 67.0 (59.0–74.0) | 67.0 (62.0–71.0) | 0.984 |
Male/Female | 101/59 | 101/59 | 1.000b |
Diabetes mellitus (%) | 28.75 | 28.75 | 1.000b |
BMI (kg/m2) | 28.4 (25.7–31.2) | 29.1 (25.9–32.0) | 0.368 |
Creat (umol/L) | 97 (86–115) | 99 (87–116) | 0.517 |
Chol (mmol/L) | 4.27 (3.73–4.94) | 4.50 (3.95–5.55) | 0.046 |
TG (mmol/L) | 1.62 (1.12–2.18) | 1.58 (1.17–2.21) | 0.644 |
LDL (mmol/L) | 2.66 (2.27–3.19) | 2.96 (2.45–3.67) | 0.003 |
HDL (mmol/L) | 1.25 (1.02–1.51) | 1.21 (1.00–1.42) | 0.354 |
hs-CRP (mg/L) | 1.71 (0.82–3.76) | 1.70 (0.85–3.88) | 0.978 |
ACSy (stemi/nstemi) (%) | 62.78 | 72.50 | 0.056b |
Multi vessel dissease (%) | 57.5 | 49.38 | 0.145b |
B2/C lesions (%) | 68.11 | 68.48 | 0.940b |
Stent diameter (mm) | 3.0 (2.0–4.5)a | 3.0 (2.0–4.0)a | 0.214 |
Stent lenght (mm) | 19 (8–68)a | 19 (8–86)a | 0.680 |